Hot Stocks: MRNA gains on earnings, SBUX jumps on global sales, SOFI pops 10%, while AMD slips
cirano83/iStock via Getty Images

Moderna (MRNA), Starbucks (SBUX) and SoFi Technologies, Inc. (SOFI) each gained ground during Wednesdayâs premarket session. MRNA is up on an earnings beat, SBUX rose on the back of strong global store sales and SOFI jumped on improved full-year guidance.
On the other hand, Advanced Micro Devices (NASDAQ:AMD) stepped into the red after the company's quarterly update included forward guidance that looked soft compared to analysts' estimates.
Gainers
Moderna (MRNA) moved higher by 3.4% in premarket trading after the healthcare stock surpassed Q2 non-GAAP EPS and revenues. MRNA reported Q2 non-GAAP EPS of $5.24, which beat the forecast figure by $0.75. Additionally, MRNA delivered revenue of $4.75B -- topping estimates by $800M.
Shares of Starbucks (SBUX) ticked upward by 1.5% during premarket, as the coffeehouse chain reported that global comparable store sales rose 3% during Q3. SBUX observed that comparable sales in North America increased by 9%, offsetting a 44% plunge in China, where COVID restrictions hampered sales.
Elsewhere, SoFi Technologies, Inc. (SOFI) popped 10.8% in premarket trading as the firm raised its full-year guidance. This came as the company announced Q2 revenue and adjusted EBITDA that exceeded its projections. The online bank now sees full-year adjusted net revenue of $1.508B-$1.513B compared to the $1.49B forecasted figure.
Decliner
Advanced Micro Devices (AMD) has fallen 4.6% on Wednesday morning as the chip stock reported Q3 guidance that fell short of expectations even as it posted Q2 results that topped estimates. AMD stated that for Q3, it anticipates revenue between $6.5B and $6.9B, while analysts were expecting $6.81B. 
To gain more information about the day's best- and worst-performing stocks, head over to Seeking Alpha's On The Move section.